Business Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
August Social Media Round-Up—Q2 Results, AI Adoption, and More
Summer is coming to an end, but here at Pfizer, the work doesn’t stop when the seasons change. Before we say goodbye to the warmer weather, let’s take a look back at the month on Pfizer’s social media.In August, we highlighted the importance of our manufacturing systems, leveraged a new AI tool in our supply chain, and released a new episode of "What's In My Lab."Meanwhile, CEO Albert Bourla shared our second quarter results, shared how Pfizer is taking on AI adoption, and sat down with TIME...
How Pfizer Thinks About AI
At Pfizer, our ambition is to be the most AI-forward company in our industry, and we are making great progress every day. I spend more time thinking about it than almost anything else because I believe this is an unprecedented opportunity. AI will fundamentally improve how we discover medicines, how we develop and manufacture them and how quickly we reach patients. Very few technologies can change every corner of a business in this way.AI adoption is one thing — nearly every company has done it...
Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business
Here at Pfizer, we are in the business of breakthroughs, and while our focus is on making advancements that impact patients’ lives, we are also aware of our work’s broader impact on the world. Every year, we take stock of the impact our work has on the world, the environment, and people themselves in our Impact Report.The 2025 Impact Report provides an overview of Pfizer's priorities and goals related to responsible business growth, which are aimed at contributing to long-term value creation and...
December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More
Happy New Year! Pay some final respects to 2025 with our monthly look back at Pfizer’s social channels.In the final month of the year, Pfizer shared an exciting innovation in cancer research, highlighted challenges faced by community-based organizations, and raised awareness for Alopecia Areata and sickle cell.Meanwhile, CEO Albert Bourla recognized the Pfizer team for our accomplishments in 2025 and shared his optimism for the upcoming year, highlighted our presence at major conferences, and...
November Social Media Round-Up—Third-Quarter Earnings, Metsera Acquisition, and More
This past November, our plates weren’t the only things that were full. Pfizer’s social channels are bursting with updates—head over to our corporate channels for the latest news.Pfizer launched two new video series: “Rewrite the Recipe” and “Equity in AA Care,” celebrated The Pfizer Foundation winning a 2025 Citizens Award, and spotlighted caregivers for Lung Cancer Awareness month.CEO Albert Bourla announced the completion of Pfizer’s acquisition of Metsera, welcomed our new colleagues, and...
Pfizer Awarded Diamond Resiliency Badge for Supply Chain Excellence
For nearly two centuries, Pfizer has been dedicated to developing medicines that change people’s lives and ensuring that people all over the globe have access to those medicines. This commitment extends beyond the discovery and production of new, more effective treatments to efficiently distributing those treatments to the people, communities, and countries that need them. We couldn’t do that without an efficient and resilient supply chain.The strength of pharmaceutical supply chains has never...
Pfizer CEO Albert Bourla Discusses Curing the Epidemic of Exclusion at APEC CEO Summit
This week, the annual APEC CEO Summit was held in San Francisco, California. The Summit brought CEOs, entrepreneurs, thought leaders and other stakeholders together with senior political leaders from the Asia-Pacific region for two days of dialogue. This year’s Summit focused on “Creating Economic Opportunity” via sustainability, inclusion, resilience, and innovation.On Thursday, Pfizer CEO Albert Bourla delivered one of the Summit CEO Spotlight speeches, with remarks focused on “Curing the...
October Social Media Round-Up—Israel-Hamas War, COVID-19 Treatment News, and Pfizer Makes Forbes List
October was an eventful month, both around the world and here at Pfizer. In this edition of the monthly social media round-up, our leadership weighs in on both. CEO Albert Bourla expresses sadness and resolve over the geopolitical upheaval in the middle east, which has far-reaching implications, including impact on many employees in the Pfizer family. He also spreads the news about our new deal with the U.S. government regarding the COVID-19 antiviral oral treatment. And our Chief Marketing...
September Social Media Round-Up—DEI, CMO, and Rocky Mount Resumes
This September, Albert Bourla, Pfizer’s CEO, attended Black Corporate Directors Conference to discuss minority representation across all sectors, and our social roundup starts with his thoughts on their mission. Our Chief Marketing Officer discusses his first year as Pfizer’s first CMO and where we go from here. It’s an illuminating read from an innovative thinker. In other news, we made a TIME Magazine list, announced a new plan to make sure clinical trials participants have access to their...
August Social Media Round-Up—Financial Update, World Humanitarian Day, RSV Vaccine
August typically brings two things: the dog days of summer and a lot of vacations! Social media tends to be a little quieter than usual, but that doesn’t mean there wasn’t plenty of activity on the Pfizer side of things. Our CEO provided a financial update, we celebrated World Humanitarian Day, and approvals for a pair of important vaccines. Catch up below. FROM OUR LEADERSHIP CEO Albert Bourla provides an update on Pfizer’s financial performance in the 2nd quarter: https://www.linkedin.com...
July Social Media Round-Up—Rocky Mount Update, Rady Johnson Honored, and Vaccine Progress
On July 20, a tornado touched down in North Carolina, injuring 16 people and damaging a Pfizer plant in Rocky Mount, one of the largest manufacturers of sterile injectable drugs in the world. This month’s social media round-up kicks off with a statement from CEO Albert Bourla about the tornado and its impact on Pfizer. In other news, we also announced a new partnership in drug discovery, helped our summer workers settle in, and saw positive results in vaccine development. Catch up below. FRO...
Pfizer’s Social Media Round-Up—June Edition
As a Fortune 50 company at the forefront of healthcare and science, Pfizer leadership consistently leads the conversation, drives discussion, and impacts markets. It can be tough to keep up with the constant flow of content as the company, our executives, and our initiatives make news online, in the business world, and in our lives. So, in this new monthly series, we’ll help you stay abreast of some of the ways Pfizer is breaking through the noise, by highlighting some of our thought leaders’...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.